IP Forum for Life Sciences

Intangible assets are the crown jewels of the world’s most valuable life sciences companies.

Today’s IP executives face seemingly limitless opportunities to leverage intangible assets, with a commensurate volume of threats. As a result, they must be as informed, nimble, and forward-thinking as any corporate leaders, for the success of their companies and the improvement of life across the globe.

View helpful transportation options here.

Advisory Board:

• Bryan Boyle Vice President, Legal Alkahest
• Kerri Braun Deputy General Counsel, Intellectual Property Kids II
• Jeffrey Butler Head of Intellectual Property, Biotechnology Lonza
• Jennifer Chung Chief Intellectual Property Counsel Accuweather
• Colm Dobbyn Group Executive and Associate General Counsel, Intellectual Property MasterCard
• David Dutcher Chief Patent Counsel Western Digital
• Jesse Fecker Senior Director, Chief U.S. Patent Counsel Ferring Pharmaceuticals
• Berrie Goldman Intellectual Property Lead Invitae
• Colin Heitzmann Senior Corporate Attorney, Legal Affairs Otsuka Pharmaceuticals
• Chris Lhulier Assistant Chief Intellectual Property Counsel DuPont
• Heidi Martinez Chief Intellectual Property Counsel Xerox
• Kevin McGough Vice President, Intellectual Property Takeda
• Shaun Montana Chief Intellectual Property Counsel Osram Sylvania
• Bruce Wu Vice President, Intellectual Property Nutcracker Therapeutics, Inc.
• Ashley Zito Chief Intellectual Property Counsel IHG

Please view Consero’s health and safety protocols for in-person events here.